Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Work In Process (2016 - 2019)

Ironwood Pharmaceuticals (IRWD) has disclosed Work In Process for 2 consecutive years, with $392000.0 as the latest value for Q4 2019.

  • Quarterly Work In Process changed N/A to $392000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $392000.0 through Dec 2019, changed N/A year-over-year, with the annual reading at $392000.0 for FY2019, N/A changed from the prior year.
  • Work In Process hit $392000.0 in Q4 2019 for Ironwood Pharmaceuticals, down from $707000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $707000.0 in Q3 2019 to a low of $71000.0 in Q4 2016.